However, performance against the 62 day cancer treatment target decreased to the lowest proportion on record since comparable data was first collected.
Fodd bynnag, gostyngodd perfformiad yn erbyn y targed 62 diwrnod ar gyfer trin canser i’r gyfran isaf ar gofnod ers casglu data cymaradwy am y tro cyntaf.